As of close of business last night, Sunshine Biopharma Inc’s stock clocked out at $0.06, up 8.38% from its previous closing price of $0.05. In other words, the price has increased by $+0.0044 from its previous closing price. On the day, 5163595 shares were traded. SBFM stock price reached its highest trading level at $0.0571 during the session, while it also had its lowest trading level at $0.0526.
Ratios:
To gain a deeper understanding of SBFM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.11 and its Current Ratio is at 5.00. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 08 when Slilaty Steve N. bought 20,000 shares for $0.10 per share. The transaction valued at 2,000 led to the insider holds 30,000 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 2.86M and an Enterprise Value of -15.31M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.15 while its Price-to-Book (P/B) ratio in mrq is 0.07. Its current Enterprise Value per Revenue stands at -0.75 whereas that against EBITDA is 0.59.
Stock Price History:
Over the past 52 weeks, SBFM has reached a high of $1.40, while it has fallen to a 52-week low of $0.05. The 50-Day Moving Average of the stock is 0.2192, while the 200-Day Moving Average is calculated to be 0.3763.
Shares Statistics:
It appears that SBFM traded 1.83M shares on average per day over the past three months and 10.09M shares per day over the past ten days. A total of 54.45M shares are outstanding, with a floating share count of 45.73M. Insiders hold about 16.02% of the company’s shares, while institutions hold 11.85% stake in the company. Shares short for SBFM as of Jan 31, 2024 were 102.64k with a Short Ratio of 0.06, compared to 114.73k on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 0.37% and a Short% of Float of 0.43%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.16 and -$0.16 for the fiscal current year, implying an average EPS of -$0.16. EPS for the following year is $0.09, with 1 analysts recommending between $0.09 and $0.09.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $44.4M in the next fiscal year. The high estimate is $44.4M and the low estimate is $44.4M. The average revenue growth estimate for next year is up 97.20% from the average revenue estimate for this year.
